Washington: A new study has suggested that children born to women who take certain antidepressants, including selective serotonin reuptake inhibitors, during the first trimester of pregnancy may modestly increase the risk of developing autism spectrum disorder (ASD).
Additionally, after adjustment for a history of depression during the year prior to delivery, SSRI exposure during the first trimester remained significantly associated with risk of ASD, as was a history of SSRI exposure at any point during the year prior to delivery. “Although the number of children exposed prenatally to selective serotonin reuptake inhibitors in this population was low, results suggest that exposure, especially during the first trimester, may modestly increase the risk of ASD,” the authors concluded. The study is published online in the Archives of General Psychiatry, one of the JAMA/Archives journals. ANI
Narendra Modi flies to Brazil for BRICS Summit
Dilip Kumar`s ancestral home declared national heritage in Pak
Govt prepares list of five governors for Raj Bhawans
UPSC aspirants protest outside Rajnath Singh`s residence